Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid

Shirsath, N; Wagner, K; Tangermann, S; Schlederer, M; Ringel, C; Kenner, L; Brune, B; Wolf, P.
8-Methoxypsoralen Plus Ultraviolet A Reduces the Psoriatic Response to Imiquimod in a Murine Model
ACTA DERM-VENEREOL. 2018; 98(6): 576-584.
Web of Science PubMed FullText FullText_MUG

 

Autor/innen der Med Uni Graz:
Kenner Lukas
Shirsath Nitesh Pralhad
Wagner Karin
Wolf Peter
Altmetrics:

Dimensions Citations:

Plum Analytics:
Abstract:
The effects of 8-Methoxypsoralen plus ultraviolet A (PUVA) or ultraviolet B (UVB) alone on imiquimodinduced psoriasis were examined in a mouse model. Mouse skin was treated with repetitive sub-phototoxic doses of PUVA or UVB before or during the induction of toll-like receptor 7/8 activation and psoriasis through the application of imiquimod. PUVA, to a greater degree than UVB, suppressed the established imiquimod-induced psoriatic phenotype, but pretreatment with PUVA prior to administration of imiquimod also reduced the susceptibility of murine skin to respond to imiquimod to a greater degree than did pretreatment with UVB. PUVA downregulated baseline levels of miRNA27a and 29a, as well as interferon-., interleukin-17 and -9, cytokines, which drive psoriatic inflammation. Microarray analysis showed enrichment of senescence pathway genes linked to upregulation of p16/p21 proteins after PUVA pretreatment. However, the anti-psoriatic effect of PUVA was lost when there was an interval of 7 days between final exposure to PUVA and the start of administration of imiquimod. This indicated that (UVB and) PUVA diminished imiquimodinduced established psoriatic inflammation, but also primed the skin in favour of a reduced responsiveness to toll-like receptor activation.

Find related publications in this database (Keywords)
psoriasis
PUVA
UVB
imiquimod
interleukin-9
senescence
© Meduni Graz Impressum